Viewing Study NCT06532812


Ignite Creation Date: 2025-12-26 @ 10:18 PM
Ignite Modification Date: 2026-01-03 @ 4:35 AM
Study NCT ID: NCT06532812
Status: RECRUITING
Last Update Posted: 2024-11-12
First Post: 2024-07-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: TIL Gean Therapy Combined With Immunotherapy for Advanced or Metastatic Refractory Breast Cancer
Sponsor: Essen Biotech
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module